enfr

RespInnovation SAS over the last 6 years has conceptualized, designed, and developed a 2nd generation 'focused pulse' High Frequency Chest Wall Oscillation device capable of aiding in bronchial airway clearance for a much wider range of patients  and clinical conditions than existing High Frequency Chest Wall Oscillation/Chest Compression devices.

RespIn 11 benefits from a totally new innovative approach to the 30 year old concept of High Frequency Chest Wall Oscillation/Chest Compression therapy and makes maximum use of modern technologies and materials to:  

  • Delivers therapeutic 'focused pulse' therapy direct to selected parts of the patient thorax creating a more profound and efficient resonance in the bronchial airways which is delivered in a comfortable 'massage like' therapy.
  • Flexibility of RespIn 11’s 'focused pulse' technology also gives treating clinicians greatly increased control and flexibility of therapy to best meet the needs of each individual patient and clinical condition.
  • Very low Background Pressure - The RespIn 11 patented system of focused pulsations operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for expectoration.
  • No negative physiological side effects - as a beneficial side effect of its low operating pressure of RespIn 11’s 'focused pulse' technology, it has no negative side effects to the patient’s physiological parameters, e.g. blood pressure and heart rate, and the RespIn 11 can therefore be safely used with a much wider range of patients and clinical conditions than existing Chest Compression devices.

 

Advantages - The RespIn 11 also has significant advantages which open up whole new clinical conditions and patients to the benefits of its 'focused pulse' therapeutic action:

  • The RespIn 11 has a very low level of clinically measurable impact on the physiological state of the patient during therapy sessions with no negative measured effects on heart rate, blood pressure, ECG, etc. - unlike the existing HFCWO/Chest Compression devices which cause patients significant physiological changes and distress.
  • This means not only a wider range of potential patients in clinical situations, but also a much higher regular usage rate for Home Care patients because of its pleasant massage effect leading to better long term results with accompanying improvements in quality of life and decreased frequency of acute acerbations.

 

Clinical Areas and applications where RespInnovation’s 'focused pulse' technology could be used more effectively than existing Chest Compression devices:

  • The elderly, both as a preventative therapy to prevent lung infections and also a secretion clearance system once they have an infection.
  • The long term bed care patient.
  • Intensive care and post-operative patients.
  • Neuro-muscular disease patients, MS, ALS, etc.